Current animal models of bronchial asthma

Current Pharmaceutical Design

Volumn 12, Issue 25, 2006, Pages 3175-3194

  Kurucz, Istvan ^a   Szelenyi, I ^a  

^a TEVA PHARMACEUTICALS   (Israel)

Author keywords

Airway hyperresponsiveness; Allergic reaction; Animal models; Asthma; Inflammation; Remodeling

Indexed keywords

ANTIASTHMATIC AGENT; BETA LACTOGLOBULIN; BOVINE SERUM ALBUMIN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE ANTIBODY; GAMMA INTERFERON; GROWTH FACTOR; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OVALBUMIN; RANTES;

ANATOMICAL VARIATION; ASTHMA; B LYMPHOCYTE; BASIC RESEARCH; BRONCHUS REACTIVITY; CAT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONICITY; CLINICAL RESEARCH; CYTOKINE PRODUCTION; DISEASE MODEL; DOG; DRUG EFFICACY; ENVIRONMENTAL FACTOR; EOSINOPHILIA; EPITHELIUM CELL; EXPERIMENTATION; FERRET; FIBROBLAST; GENETICS; GUINEA PIG; HORSE; MACROPHAGE; MAST CELL; MONKEY; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PATHOPHYSIOLOGY; POLLEN; PRIORITY JOURNAL; RABBIT; RAT; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; SENSITIZATION; SHEEP; SHEEP ERYTHROCYTE; SMOOTH MUSCLE FIBER; SPECIES DIFFERENCE; SWINE; TH1 CELL; TH2 CELL;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; HUMANS; SPECIES SPECIFICITY;

EID: 33748546919     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206778194169     Document Type: Review

References (271)

1. Floyer, J. A treatise of the asthma. In Brewis LAL (ed) Classic papers in asthma Vol I p 30, Science Press Ltd., London 1990.
2. Epstein MM. Do mouse models of allergic asthma mimic clinical disease? Int Arch Allergy Immunol 2004; 133: 84-100.
3. Isenberg-Feig H, Justice JP, Keane-Myers A. Animal models of allergic asthma. Curr Allergy Asthma Rep 2003; 3: 70-8.
4. Kips JC, Anderson GP, Fredberg JJ, Herz U, Inman MD, Jordana M, et al. Murine models of asthma. Eur Respir J 2003; 22: 374-82.
5. Gelfand EW. Pro: mice are a good model of human airway disease. Am J Respir Crit Care Med 2002; 166: 5-6;
6. Persson CG. Con: mice are not a good model of human airway disease. Am J Respir Crit Care Med 2002; 166: 6-7;
7. Kasai M, Kurasawa Y, Nakajima H, Iwamoto I. T cell vaccination eliminates antigen-specific T cells and prevents antigen-induced eosinophil recruitment into the tissue. Int Arch Allergy Immunol 2001; 125 Suppl 1: 59-66.
8. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med. 1995; 182: 1527-36.
9. Adel-Patient K, Nahori MA, Proust B, Lapa e Silva JR, Creminon C, et al. Elicitation of the allergic reaction in beta-lactoglobulin-sensitized Balb/c mice: biochemical and clinical manifestations differ according to the structure of the allergen used for challenge. Clin Exp Allergy 2003; 33: 376-85.
10. Mehlhop PD, van de Rijn M, Goldberg AB, Brewer JP, Kurup VP, Martin TR, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA 1997; 94: 1344-9.
11. Kim J, Merry AC, Nemzek JA, Bolgos GL, Siddiqui J, Remick DG. Eotaxin represents the principal eosinophil chemoattractant in a novel murine asthma model induced by house dust containing cockroach allergens. J Immunol 2001; 167: 2808-15.
12. Tategaki A, Kawamoto S, Okuda T, Aki T, Yasueda H, Suzuki O, et al. A high-molecular-weight mite antigen (HMI) fraction aggravates airway hyperresponsiveness of allergic mice to house dusts and whole mite cultures. Int Arch Allergy Immunol 2002; 129: 204-11.
13. Bauer L, Bohle B, Jahn-Schmid B, Wiedermann U, Daser A, Renz H, et al. Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1. Clin Exp Immunol 1997; 107: 536-41.
14. Zhang Y, Lamm WJ, Albert RK, Chi EY, Henderson WR Jr, Lewis DB. Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am J Respir Crit Care Med 1997; 155: 661-9.
15. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998; 53: 849-56.
16. Cieslewicz G, Tomkinson A, Adler A, Duez C, Schwarze J, Takeda K, et al. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest 1999; 104: 301-8.
17. de Siqueira AL, Russo M, Steil AA, Facincone S, Mariano M, Jancar S. A new murine model of pulmonary eosinophilic hypersensitivity: contribution to experimental asthma. J Allergy Clin Immunol 1997; 100: 383-8.
18. Graffi SJ, Dekan G, Stingl G, Epstein MM. Systemic administration of antigen-pulsed dendritic cells induces experimental allergic asthma in mice upon aerosol antigen rechallenge. Clin Immunol 2002; 103: 176-84.
19. Hopfenspirger MT, Agrawal DK. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol 2002; 168: 2516-22.
20. Crosby JR, Cieslewicz G, Borchers M, Hines E, Carrigan P, Lee JJ, et al. Early phase bronchoconstriction in the mouse requires allergen-specific IgG. J Immunol 2002; 168: 4050-4.
21. Canning BJ. Overview of animal models of asthma. In Enna SJ, Williams M, Ferkany JW, Kenakin T, Porsolt RD, Sullivan JP (Eds) Current protocols in Pharmacology 5.25.1-5.25.15, Wiley & Son Inc., New York 2002.
22. Whitehead GS, Walker JK, Berman KG, Foster WM, Schwartz DA. Allergen-induced airway disease is mouse strain dependent. Am J Physiol Lung Cell Mol Physiol 2003; 285: L32-42.
23. Hessel EM, Van Oosterhout AJ, Hofstra CL, De Bie JJ, Garssen J, Van Loveren H, et al. Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice. Eur J Pharmacol 1995; 293: 401-12.
24. Takeda K, Haczku A, Lee JJ, Irvin CG, Gelfand EW. Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am J Physiol Lung Cell Mol Physiol 2001; 281: L394-402.
25. Ewart SL, Kuperman D, Schadt E, Tankersley C, Grupe A, Shubitowski DM, et al. Quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice. Am J Respir Cell Mol Biol 2000; 23: 537-45.
26. Yasue M, Yokota T, Suko M, Okudaira H, Okumura Y. Comparison of sensitization to crude and purified house dust mite allergens in inbred mice. Lab Anim Sci. 1998; 48: 346-52.
27. Konno S, Adachi M, Matsuura T, Sunouchi K, Hoshino H, Okazawa A, et al. Bronchial reactivity to methacholine and serotonin in six inbred mouse strains Arerugi. 1993; 42: 42-7.
28. Brewer JP, Kisselgof AB, Martin TR. Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. Am J Respir Crit Care Med 1999; 160: 1150-6.
29. Eum SY, Haile S, Lefort J, Huerre M, Vargaftig BB. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci USA 1995; 92: 12290-4.
30. Townley RG, Horiba M. Airway hyperresponsiveness: a story of mice and men and cytokines.Clin Rev Allergy Immunol 2003; 24: 85-110.
31. Renz H, Smith HR, Henson JE, Ray BS, Irvin CG, Gelfand EW. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol 1992, 89: 1127-38.
32. Dohi M, Tsukamoto S, Nagahori T, Shinagawa K, Saitoh K, Tanaka Y, et al. Noninvasive system for evaluating the allergen-specific airway response in a murine model of asthma. Lab Invest 1999; 79: 1559-71.
33. Gonzalo JA, Lloyd CM, Kremer L, Finger E, Martinez-A C, Siegelman MH, et al. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest 1996: 98: 2332-45.
34. Yang L, Cohn L, Zhang DH, Homer R, Ray A, Ray P. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J Exp Med 1998; 188: 1739-50.
35. Humbles AA, Lu B, Nilsson CA, Lilly C, Israel E, Fujiwara Y, et al. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 2000; 406: 998-1001.
36. Tomkinson A, Cieslewicz G, Duez C, Larson KA, Lee JJ, Gelfand EW. Temporal association between airway hyperresponsiveness and airway eosinophilia in ovalbumin-sensitized mice. Am J Respir Crit Care Med 2001; 163: 721-30.
37. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-9.
38. Kung TT, Jones H, Adams GK 3rd, Umland SP, Kreutner W, Egan RW, et al. Characterization of a murine model of allergic pulmonary inflammation. Int Arch Allergy Immunol 1994; 105: 83-90.
39. Carlsson CG, Erjefalt JS, Korsgren M, Sundler F. The mouse trap. Trends Pharmacol Res 1997; 18: 465-67.
40. Kennedy JD, Hatfield CA, Fidler SF, Winterrowd GE, Haas JV, Chin JE, et al. Phenotypic characterization of T lymphocytes emigrating into lung tissue and the airway lumen after antigen inhalation in sensitized mice. Am J Respir Cell Mol Biol 1995; 12: 613-23.
41. Tang C, Inman MD, van Rooijen N, Yang P, Shen H, Matsumoto K, et al. Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol 2001; 166: 1471-81.
42. Trifilieff A, El-Hashim A, Bertrand C. Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1120-8.
43. Pan ZZ, Parkyn L, Ray A, Ray P. Inducible lung-specific expression of RANTES: preferential recruitment of neutrophils. Am J Physiol Lung Cell Mol Physiol 2000; 279: L658-66.
44. Becker S, Reed W, Henderson FW, Noah TL. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES. Am J Physiol 1997; 272: L512-20.
45. MacLean JA, Sauty A, Luster AD, Drazen JM, De Sanctis GT. Antigen-induced airway hyperresponsiveness, pulmonary eosinophilia, and chemokine expression in B cell-deficient mice. Am J Respir Cell Mol Biol 1999; 20: 379-87.
46. Takeda K, Hamelmann E, Joetham A, Shultz LD, Larsen GL, Irvin CG, et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 1997; 186: 449-54.
47. Holt PG, Rose AH, Batty JE, Turner KJ. Induction of adjuvant-independent IgE responses in inbred mice: primary, secondary, and persistent IgE responses to ovalbumin and ovomucoid. Int Arch Allergy Appl Immunol 1981; 65: 42-50.
48. Fan T, Yang M, Halayko A, Mohapatra SS, Stephens NL. Airway responsiveness in two inbred strains of mouse disparate in IgE and IL-4 production. Am J Respir Cell Mol Biol 1997; 17: 156-63.
49. Takizawa H. Airway epithelial cells as regulators of airway inflammation. Int J Mol Med 1998; 1: 367-78.
50. Path G, Braun A, Meents N, Kerzel S, Quarcoo D, Raap U, et al. Augmentation of allergic early-phase reaction by nerve growth factor. Am J Respir Crit Care Med 2002; 166: 818-26.
51. Honda K, Arima M, Cheng G, Taki S, Hirata H, Eda F, et al. Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J Exp Med 2003; 198: 533-43.
52. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103: 779-88.
53. Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR, Lo D.Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999 Mar 1; 162: 2477-87.
54. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 1998; 282: 2258-61.
55. Hertz M, Mahalingam S, Dalum I, Klysner S, Mattes J, Neisig A, et al. Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma. J Immunol 2001; 167: 3792-9.
56. Makela MJ, Kanehiro A, Borish L, Dakhama A, Loader J, Joetham A, et al. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci USA 2000; 97: 6007-12.
57. Kobayashi T, Miura T, Haba T, Sato M, Serizawa I, Nagai H, et al. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J Immunol 2000; 164: 3855-61.
58. Herz U, Braun A, Ruckert R, Renz H. Various immunological phenotypes are associated with increased airway responsiveness. Clin Exp Allergy 1998; 28: 625-34.
59. Silkoff PE, McClean PA, Slutsky AS, Caramori M, Chapman KR, Gutierrez C, et al. Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma. J Asthma 1998; 35: 473-9.
60. Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998: 12: 929-37.
61. Vaali K, Li L, Redemann B, Paakkari I, Vapaatalo H. In-vitro bronchorelaxing effects of novel nitric oxide donors GEA 3268 and GEA 5145 in guinea-pigs and rats. J Pharm Pharmacol 1996; 48: 1309-14.
62. Sadeghi-Hashjin G, Folkerts G, Henricks PA, Verheyen AK, van der Linde HJ, van Ark I, et al. Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med 1996; 153: 1697-701.
63. De Sanctis GT, MacLean JA, Hamada K, Mehta S, Scott JA, Jiao A, et al. Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med 1999; 189: 1621-30.
64. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183: 195-201.
65. Kaminuma O, Mori A, Suko M, Kikkawa H, Naito K, Okudaira H. Development of lung eosinophilic inflammation by the infusion of IL-5-producing T cell clones. Int Arch Allergy Immunol 1997; 114 Suppl 1: 10-3.
66. Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest 1997; 99: 1329-39.
67. Taube C, Duez C, Cui ZH, Takeda K, Rha YH, Park JW, et al. The role of IL-13 in established allergic airway disease. J Immunol 2002; 169: 6482-9.
68. Kibe A, Inoue H, Fukuyama S, Machida K, Matsumoto K, Koto H, et al. Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am J Respir Crit Care Med 2003, 167: 50-6.
69. Whittaker L, Niu N, Temann UA, Stoddard A Flavell RA, Ray A et al. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am J Respir Cell Mol Biol 2002; 27: 593-602.
70. Blyth DI, Pedrick MS, Savage TJ, Bright H, Beesley JE, Sanjar S. Induction, duration, and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone. Am J Respir Cell Mol Biol 1998; 19: 38-54.
71. Blyth DI, Wharton TF, Pedrick MS, Savage TJ, Sanjar S. Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody. Am J Respir Cell Mol Biol 2000; 23: 241-6.
72. Leigh R, Ellis R, Wattie J, Southam DS, de Hoogh M, Gauldie J, et al. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 2002; 27: 526-535.
73. Shinagawa K, Kojima M. Mouse model of airway remodeling: strain differences. Am J Respir Crit Care Med 2003, 168: 959-967.
74. Korsgren M, Erjefalt JS, Korsgren O, Sundler F, Persson CG. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 1997; 185: 885-92.
75. Malm-Erjefalt M, Persson CG, Erjefalt JS. Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. Am J Respir Cell Mol Biol 2001; 24: 352-9.
76. Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000; 105: 193-204.
77. Kumar RK. Understanding airway wall remodeling in asthma: a basis for improvements in therapy? Pharmacol Therapeut 2001; 91: 93-104.
78. Kumar RK, Foster PS. Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 2002; 27: 267-72.
79. Kenyon N, Ward RW, Last JA. Airway fibrosis in a mouse model of airway inflammation. Toxicol Appl Pharmacol 2003; 186: 90-100.
80. Yiamouyiannis CA, Schramm CM, Puddington L, Stengel P, Baradaran-Hosseini E, Wolyniec WW, et al. Shifts in lung lymphocyte profiles correlate with the sequential development of acute allergic and chronic tolerant stages in a murine asthma model. Am J Pathol 1999; 154: 1911-21.
81. Collins RA, Sly PD, Turner DJ, Herbert C, Kumar RK. Site of inflammation influences site of hyperresponsiveness in experimental asthma. Respir Physiol Neurobiol 2003; 139: 51-61.
82. Johnson JR, Wiley RE, Fattouh R, Swirski FK, Gajewska BU, Coyle AJ, et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med 2004; 169: 378-85.
83. Leong KP, Huston DP. Understanding the pathogenesis of allergic asthma using mouse models. Ann Allergy Asthma Immunol 2001; 87: 96-109.
84. Karras JG, McGraw K, McKay RA, Cooper SR, Lerner D, Lu T, et al. Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma. J Immunol 2000; 164: 5409-15.
85. Pabst R, Tschernig T. Perivascular capillaries in the lung: an important but neglected vascular bed in immune reactions? J Allergy Clin Immunol 2002; 110: 209-14.
86. Canning BJ. Modeling asthma and COPD in animals: a pointless exercise? Curr Opin Pharmacol 2003; 3: 244-50.
87. Joachim RA, Quarcoo D, Arck PC, Herz U, Renz H, Klapp BF. Stress enhances airway reactivity and airway inflammation in an animal model of allergic bronchial asthma. Psychosom Med 2003; 65: 811-5.
88. Glaab T, Hoymann HG, Hecht M, Korolewitz R, Tschernig T, Hohlfeld JM, Krug N, Braun A. Effect of anti-nerve growth factor on early and late airway responses in allergic rats. Allergy 2003; 58: 900-4.
89. Dong W, Selgrade MK, Gilmour MI. Systemic administration of Bordetella pertussis enhances pulmonary sensitization to house dust mite in juvenile rats. Toxicol Sci 2003; 72: 113-21.
90. Warbrick EV, Dearman RJ, Kimber I. IgG and IgE antibody responses following exposure of Brown Norway rats to trimellitic anhydride: comparison of inhalation and topical exposure. Toxicology 2002; 172: 157-68.
91. Misawa M, Chiba Y. Repeated antigenic challenge-induced airway hyperresponsiveness and airway inflammation in actively sensitized rats. Jpn J Pharmacol 1993, 61: 41-50.
92. Vanacker NJ, Palmans E, Pauwels RA, Kips JC. Fluticasone inhibits the progression of allergen-induced structural airway changes.Clin Exp Allergy 2002; 32: 914-20.
93. Carvalho C, Jancar S, Mariano M, Sirois P. A rat model presenting eosinophilia in the airways, lung eosinophil activation, and pulmonary hyperreactivity.Exp Lung Res 1999; 25: 303-16.
94. Singh P, Daniels M, Winsett DW, Richards J, Doerfler D, Hatch G, Adler KB, Gilmour MI. Phenotypic comparison of allergic airway responses to house dust mite in three rat strains.Am J Physiol Lung Cell Mol Physiol 2003; 284: L588-98.
95. Careau E, Sirois J, Bissonnette EY. Characterization of lung hyperresponsiveness, inflammation, and alveolar macrophage mediator production in allergy resistant and susceptible rats.Am J Respir Cell Mol Biol 2002; 26: 579-86.
96. Watanabe A, Hayashi H. Allergen-induced biphasic bronchoconstriction in rats.Int Arch Allergy Appl Immunol 1990; 93: 26-34.
97. Waserman S, Xu LJ, Olivenstein R, Renzi PM, Martin JG. Association between late allergic bronchoconstriction in the rat and allergen-stimulated lymphocyte proliferation in vitro. Am J Respir Crit Care Med 1995; 151: 470-4.
98. Lambert AL, Winsett DW, Costa DL, Selgrade MK, Gilmour MI. Transfer of allergic airway responses with serum and lymphocytes from rats sensitized to dust mite.Am J Respir Crit Care Med 1998; 157: 1991-9.
99. Waserman S, Olivenstein R, Renzi P, Xu LJ, Martin JG. The relationship between late asthmatic responses and antigen-specific immunoglobulin. J Allergy Clin Immunol 1992; 90: 661-9.
100. Hojo M, Maghni K, Issekutz TB, Martin JG. Involvement of alpha-4 integrins in allergic airway responses and mast cell degranulation in vivo. Am J Respir Crit Care Med 1998; 158: 1127-33.
101. Xu L, Olivenstein R, Martin JG, Powell WS. Inhaled budesonide inhibits OVA-induced airway narrowing, inflammation, and cys-LT synthesis in BN rats. J Appl Physiol 2000; 89: 1852-8.
102. Bellofiore S, Martin JG. Antigen challenge of sensitized rats increases airway responsiveness to methacholine. J Appl Physiol 1988; 65: 1642-6.
103. Allakhverdi Z, Allam M, Renzi PM. Inhibition of antigen-induced eosinophilia and airway hyperresponsiveness by antisense oligonucleotides directed against the common beta chain of IL-3, IL-5, GM-CSF receptors in a rat model of allergic asthma. Am J Respir Crit Care Med 2002; 165: 1015-21.
104. Kips JC, Cuvelier CA, Pauwels RA. Effect of acute and chronic antigen inhalation on airway morphology and responsiveness in actively sensitized rats.Am Rev Respir Dis 1992; 145: 1306-10.
105. Kamachi A, Nasuhara Y, Nishimura M, Takahashi T, Homma Y, Ohtsuka Y, Munakata M. Dissociation between airway responsiveness to methacholine and responsiveness to antigen. Eur Respir J 2002; 19: 76-83.
106. Andrew DK, Schellenberg RR, Hogg JC, Hanna CJ, Pare PD. Physiological and immunological effects of chronic antigen exposure in immunized guinea pigs. Int Arch Allergy Appl Immunol 1984; 75: 208-13
107. Cui ZH, Sjostrand M, Pullerits T, Andius P, Skoogh BE, Lotvall J. Bronchial hyperresponsiveness, epithelial damage, and airway eosinophilia after single and repeated allergen exposure in a rat model of anhydride-induced asthma. Allergy 1997; 52: 739-46.
108. Elwood W, Lotvall JO, Barnes PJ, Chung KF. Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized brown-Norway rats. J Allergy Clin Immunol 1991; 88: 951-60.
109. Huang TJ, Newton R, Haddad EB, Chung KF. Differential regulation of cytokine expression after allergen exposure of sensitized rats by cyclosporin A and corticosteroids: relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1999; 104: 644-52.
110. Schneider T, van Velzen D, Moqbel R, Issekutz AC. Kinetics and quantitation of eosinophil and neutrophil recruitment to allergic lung inflammation in a brown Norway rat model. Am J Respir Cell Mol Biol 1997; 17: 702-12.
111. Underwood SL, McMillan S, Reeves R, Hunt J, Brealey CJ, Webber S, Foster M, Sargent CA. Effects of cyclosporin A administered into the airways against antigen-induced airway inflammation and hyperreactivity in the rat. Eur J Pharmacol 2001; 420: 165-73.
112. Schuster M, Tschernig T, Krug N, Pabst R. Lymphocytes migrate from the blood into the bronchoalveolar lavage and lung parenchyma in the asthma model of the brown Norway rat. Am J Respir Crit Care Med 2000; 161: 558-66.
113. Huang TJ, MacAry PA, Kemeny DM, Chung KF. Effect of CD8+ T-cell depletion on bronchial hyper-responsiveness and inflammation in sensitized and allergen-exposed Brown-Norway rats. Immunology 1999; 96: 416-23.
114. Suzuki M, Taha R, Ihaku D, Hamid Q, Martin JG. CD8+ T cells modulate late allergic airway responses in Brown Norway rats. J Immunol 1999; 163: 5574-81.
115. Careau. E, Bissonnette EY. Adoptive Transfer of Alveolar Macrophages Abrogates Bronchial Hyperresponsiveness. Am J Respir Cell Mol Biol 2004; Feb 12 [Epub ahead of print].
116. Yu W, Xu L, Martin JG, Powell WS. Cellular infiltration and eicosanoid synthesis in brown Norway rat lungs after allergen challenge. Am J Respir Cell Mol Biol 1995; 13: 477-86.
117. Lin CC, Lin CY, Liaw SF, Chen A. Pulmonary function changes and immunomodulation of Th 2 cytokine expression induced by aminophylline after sensitization and allergen challenge in brown Norway rats. Ann Allergy Asthma Immunol 2002; 88: 215-22.
118. Haczku A, Macary P, Haddad EB, Huang TJ, Kemeny DM, Moqbel R, Chung KF. Expression of Th-2 cytokines interleukin-4 and -5 and of Th-1 cytokine interferon-gamma in ovalbumin-exposed sensitized Brown-Norway rats. Immunology 1996; 88: 247-51.
119. Nag SS, Xu LJ, Hamid Q, Renzi PM. The effects of IL-5 on airway physiology and inflammation in rats. J Allergy Clin Immunol 2003; 111: 558-66.
120. Chiba Y, Arimoto T, Yoshikawa T, Misawa M. Elevated nitric oxide synthase activity concurrent with antigen-induced airway hyperresponsiveness in rats. Exp Lung Res 2000; 26: 535-49.
121. Birrell MA, McCluskie K, Haddad el-B, Battram CH, Webber SE, Foster ML, Yacoub MH, Belvisi MG. Pharmacological assessment of the nitric-oxide synthase isoform involved in eosinophilic inflammation in a rat model of sephadex-induced airway inflammation. J Pharmacol Exp Ther 2003; 304: 1285-91.
122. Palmans E, Kips JC, Pauwels RA. Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med 2000; 161: 627-35.
123. Salmon M, Walsh DA, Koto H, Barnes PJ, Chung KF. Repeated allergen exposure of sensitized Brown-Norway rats induces airway cell DNA synthesis and remodelling. Eur Respir J 1999; 14: 633-41.
124. Palmans E, Pauwels RA, Kips JC. Repeated allergen exposure changes collagen composition in airways of sensitised Brown Norway rats. Eur Respir J 2002; 20: 280-5.
125. Vanacker NJ, Palmans E, Kips JC, Pauwels RA. Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am J Respir Crit Care Med 2001; 163: 674-9.
126. Moir LM, Leung SY, Eynott PR, McVicker CG, Ward JP, Chung KF, Hirst SJ. Repeated allergen inhalation induces phenotypic modulation of smooth muscle in bronchioles of sensitized rats. Am J Physiol Lung Cell Mol Physiol 2003; 284: L148-59.
127. Xu KF, Vlahos R, Messina A, Bamford TL, Bertram JF, Stewart AG. Antigen-induced airway inflammation in the Brown Norway rat results in airway smooth muscle hyperplasia. J Appl Physiol 2002; 93: 1833-40.
128. Szelenyi I. Efforts to standardize animal sensitization in asthma research. Scientific cooperation - quo vadis? Inflamm Res 2003; 52: 397-8.
129. Tigani B, Schaeublin E, Sugar R, Jackson AD, Fozard JR, Beckmann N. Pulmonary inflammation monitored noninvasively by MRI in freely breathing rats. Biochem Biophys Res Common 2002; 292: 216-21.
130. Beckmann N, Tigani B, Ekatodramis D, Borer R, Mazzoni L, Fozard JR. Pulmonary edema induced by allergen challenge in the rat: noninvasive assessment by magnetic resonance imaging. Magn Reson Med 2001; 45: 88-95.
131. Kallos P, Pagel W: Experimentelle untersuchungen uber asthma bronchiale. Acta Med Scand 1937; 91: 293-305.
132. Auer J. and Lewis PA 1910. The physiology of the immediate reaction of anaphylaxis in the guinea pig. J Exp Med 12: 151-175.
133. Dale H.H 1933. A survey of the present knowledge of the chemical regulation by natural constituents of the tissues. Bulletin of the Johns Hopkins Hospital 53: 297-347.
134. Kellaway C.H. and Trethewie E.R. 1940. The liberation of a slow-reacting smooth muscle-stimulating substance in anaphylaxis. Q. J. Exp. Physiol 31: 121-145.
135. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994; 179: 881-7.
136. Evans TW, Rogers DF, Aursudkij B, Chung KF, Barnes PJ. Inflammatory mediators involved in antigen-induced airway microvascular leakage in guinea pigs. Am Rev Respir Dis 1988; 138: 395-9.
137. Salari H, Howard S, Chan H, Dryden P, Chan-Yeung M. Involvement of immunological mechanisms in a guinea pig model of western red cedar asthma. J Allergy Clin Immunol 1994; 93: 877-84.
138. Gagnaire F, Ban M, Cour C, Micillino JC, Bonnet P, Hettich D. Role of tachykinins and neutral endopeptidase in toluene diisocyanate-induced bronchial hyperresponsiveness in guinea pigs. Toxicology 1997; 116: 17-26.
139. Hayes JP, Barnes PJ, Taylor AJ, Chung KF. Effect of a topical corticosteroid on airway hyperresponsiveness and eosinophilic inflammation induced by trimellitic anhydride exposure in sensitized guinea pigs. J Allergy Clin. Imm. 1993; 92: 450-6.
140. Hutson PA, Church MK, Clay TP, Miller P, Holgate ST. Early and late-phase bronchoconstriction after allergen challenge of nonanesthetized guinea pigs. I. The association of disordered airway physiology to leukocyte infiltration. Am Rev Respir Dis 1988a; 137: 548-57.
141. Duan W, Kuo IC, Selvarajan S, Chua KY, Bay BH, Wong WS. Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am J Respir Crit Care Med 2003; 167: 185-92.
142. Yang ZW, Qin YH, Su SR. Use of star volume to measure the size of the alveolar space in the asthmatic guinea-pig lung. Respirology 2002; 7: 117-21.
143. Konzett H, Rössler R. Versuchsanordnung zu Untersuchung an der Bronchialmuskulatur. Arch Exp Path Pharmacol 1940; 195: 71-6.
144. Mazzone SB, Caning BJ. Guinea pigs mofels of asthma. Curr Protocols Pharmacol 2002; 5.26.1-5.25.30.
145. Chand N, Diamantis W, Nolan K, Pillar J, Sofia RD. Azelastine inhibits acute allergic dyspnea in a conscious guinea pig asthma model. Res. Commun. Mol. Pathol. Pharmacol 1994; 85: 209-16.
146. 2 receptors after the early allergic reaction: Possible contribution to bronchial hyperresponsiveness in allergic guinea-pigs. Br J Pharmacol 1995; 114: 881-7.
147. Hutson PA, Holgate ST, Church MK. The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of nonanesthetized guinea pigs. Am Rev Respir Dis 1988c; 138: 1157-63.
148. Lin CH, Ko FN, Ishii H, Ishikawa T, Chen IS, Teng CM, Kuo HP. The effect of the selective PAF antagonist CIS-19 on PAF- and antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity in guinea-pigs. Naunyn Schmiedebergs Arch Pharmacol 1997; 355: 210-6.
149. De Vries A, Engels F, Henricks PA, Leusink-Muis T, Fischer A, Nijkamp FP. Antibodies directed against nerve growth factor inhibit the acute bronchoconstriction due to allergen challenge in guinea-pigs. Clin Exp Allergy 2002; 32: 325-8.
150. Aoki S, Boubekeur K, Kristersson A, Morley J, Sanjar S. Is allergic airway hypersensitivity of the guinea pig dependent on eosinophil accumulation in the lung? Br J Pharmacol 1988; 94: 365-71.
151. Hisada T, Hellewell PG, Teixeira MM, Malm MGK, Salmon M, Huang TJ, et al. Alpha(4) integrin-dependent eotaxin induction of bronchial hyperresponsiveness and eosinophil migration in interleukin-5 transgenic mice. Am J Respir Cell Mol Biol 1999; 20: 992-1000.
152. Chand N, Nolan K, Diamantis W, Sofia RD. Repeated aeroallergen challenge induces lung dysfunction but not bronchial hyperresponsiveness in conscious guinea pigs. Agents Actions 1992; 37: 181-3.
153. Perretti F, Manzini S. Activation of capsaicin-sensitive sensory fibres modulates PAF-induced bronchial hyperresponsiveness in anesthetized guinea pigs. Am Rev Respir Dis 1993; 148: 927-31
154. Fujimura M, Myou S, Nomura M, Matsuda T, Harada A, Mukaida N, Matsushima K, Nonomura A. Effect of thromboxane A2 antagonists on bronchial hyperresponsiveness induced immediately after interleukin-8 inhalation in guinea-pigs. Br J Pharmacol 1997; 122: 1015-20.
155. Kraneveld AD, Van Ark I, Van der Linde HJ, Fattah D, Nijkamp FP, Van Oosterhout AJ. Antibody to very late activation antigen 4 prevents interleukin-5-induced airway hyperresponsiveness and eosinophil infiltration in the airways of guinea pigs. J Allergy Clin Immunol 1997; 100: 242-50.
156. 2-induced airway hyperresponsiveness in guinea-pigs. Jpn J Pharmacol 1995; 67(Suppl. I): 312P.
157. Tohda Y, Haraguchi R, Itoh M, Ohkawa K, Kubo H, Fukuoka M, Nakajima S. Role of muscarinic acetylcholine receptors in a guinea pig model of asthma. Int Immunopharmacol 2002, 2: 1521-7.
158. Adamko DJ, Fryer AD, Bochner BS, Jacoby DB. CD8+ T lymphocytes in viral hyperreactivity and M2 muscarinic receptor dysfunction. Am J Respir Crit Care Med 2003; 167: 550-6.
159. Dunn CJ, Elliott GA, Oostveen JA, Richards IM. Development of prolonged eosinophil-rich inflammatory leukocyte infiltration in the guinea-pig asthmatic response to ovalbumin inhalation. Am Rev Respir Dis 1988; 137: 541-7.
160. Underwood S, Foster M, Raebum D, Bottoms S, Karlsson JA. Time-course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness. Eur Resp J 1995; 8: 2104-13
161. Lapa e Silva JR, Ruffie C, Vargaftig BB, Pretolani M. Modulation of the bronchial inflammation in sensitized guinea-pigs by FK506, nedocromil sodium and dexamethasone. Eur Respir J 1995; 8: 1321-7.
162. Weinstock M, Shoham S. Seasonal variation in sensitivity of guinea pig tissues to agonists. Nature 1974; 251: 427-8
163. Conroy DM, Humbles AA, Rankin SM, Palframan RT, Collins PD, Griffiths-Johnson DA, Jose PJ, Williams TJ. The role of the eosinophil-selective chemokine, eotaxin, in allergic and non-allergic airways inflammation. Mem. Inst. Oswaldo Cruz 1997; 92(Suppl 2): 183-91
164. Meurs H, McKay S, Maarsingh H, Hamer MA, Macic L, Molendijk N, Zaagsma J. Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br J Pharmacol 2002; 136: 391-8.
165. Lin CC, Lin CY. Bronchoconstriction and eosinophil recruitment in guinea pig lungs after platelet activating factor administration. J. Asthma 1997; 34:153-60
166. Fahy JV. Remodeling of the airway epithelium in asthma. Am J Respir Crit Care Med 2001; 164: S46-51.
167. Zhang X, Yao W, He Q. [Image analysis of airway remodeling and responsiveness in asthmatic guinea pig] Zhonghua Jie He He Hu Xi Za Zhi 2001; 24: 87-9
168. Agusti C, Takeyama K, Cardell LO, Ueki I, Lausier J, Lou YP, Nadel JA. Goblet cell degranulation after antigen challenge in sensitized guinea pigs. Role of neutrophils. Am J Respir Crit Care Med 1998; 158: 1253-8.
169. Canning BJ, Fischer A. Neural regulation of airway smooth muscle tone. Respir Physiol 2001; 125: 113-27.
170. Smith H. Animal models of asthma. Pulm. Pharmacol 1989; 2: 59-74
171. Aharony D. Pharmacology of leukotriene receptor antagonists. Am J Respir Crit Care Med 1998; 157: S214-9.
172. Shampain MP, Behrens BL, Larsen GL, Henson PM. An animal model of late pulmonary responses to Alternaria challenge. Am Rev Respir Dis 1982; 126: 493-8.
173. Marsh WR, Irvin CG, Murphy KR, Behrens BL, Larsen GL. Increases in airway reactivity to histamine and inflammatory cells in bronchoalveolar lavage after the late asthmatic response in an animal model. Am Rev Respir Dis 1985; 131: 875-9.
174. Nyce JW, Metzger WJ. DNA antisense therapy for asthma in an animal model. Nature 1997; 385: 721-5.
175. Gozzard N, Herd CM, Blake SM, Holbrook M, Hughes B, Higgs GA, et al. Effects of theophylline and rolipram on antigen-induced airway responses in neonatally immunized rabbits.Br J Pharmacol 1996; 117:1405-1.
176. Ali S, Mustafa SJ, Metzger WJ. Modification of allergen-induced airway obstruction and bronchial hyperresponsiveness in the allergic rabbit by theophylline aerosol. Agents Actions 1992; 37: 168-70.
177. Gozzard N, el-Hashim A, Herd CM, Blake SM, Holbrook M, Hughes B, et al. Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor CDP840 on antigen-induced airway responses in neonatally immunised rabbits. Br J Pharmacol 1996; 118: 1201-8.
178. Murphy KR, Wilson MC, Irvin CG, Glezen LS, Marsh WR, Haslett C, Henson PM, Larsen GL. The requirement for polymorphonuclear leukocytes in the late asthmatic response and heightened airways reactivity in an animal model. Am Rev Respir Dis 1986; 134: 62-8.
179. Coyle AJ, Page CP, Atkinson L, Sjoerdsma K, Touvay C, Metzger WJ. Modification of allergen-induced airway obstruction and airway hyperresponsiveness in an allergic rabbit model by the selective platelet-activating factor antagonist, BN 52021.J Allergy Clin Immunol 1989; 84: 960-7.
180. Ali S, Mustafa SJ, Metzger WJ. Adenosine receptor-mediated bronchoconstriction and bronchial hyperresponsiveness in allergic rabbit model. Am J Physiol 1994; 266: L271-7.
181. Bloom JW, Baumgartener-Folkerts C, Palmer JD, Halonen M. Airway cholinergic responsiveness in rabbits in relation to antigen sensitization and challenge. Immunopharmacology 1988; 15: 157-67.
182. Brown, E.J 1997. Adhesive interactions in the immune system. Trends Cell Biol. 7: 289-295.
183. el-Hashim AZ, Jacques CA, Herd CM, Lee TH, Page CP. The effect of R 15.7/ HO, an anti-CD18 antibody, on the late airway response and airway hyperresponsiveness in an allergic rabbit model.Br J Pharmacol 1997; 121: 671-8.
184. Smiley-Jewell SM, Tran MU, Weir AJ, Johnson ZA, Van Winkle LS, Plopper CG. Three-dimensional mapping of smooth muscle in the distal conducting airways of mouse, rabbit, and monkey. J Appl Physiol 2002; 93: 1506-14.
185. Szelenyi I Animal models of bronchial asthma. Inflamm Res 2000 Dec; 49(12): 639-54.
186. Abraham WM, Delehunt JC, Yerger L, Marchette B. Characterization of a late phase pulmonary response after antigen challenge in allergic sheep.Am Rev Respir Dis 1983 Nov; 128(5): 839-44.
187. Abraham WM. Pharmacology of allergen-induced early and late airway responses and antigen-induced airway hyperresponsiveness in allergic sheep.Pulm Pharmacol 1989; 2: 33-40.
188. Long WM, Yerger LD, Abraham WM, Lobel C. Late-phase bronchial vascular responses in allergic sheep. J Appl Physiol 1990; 69: 584-90.
189. Abraham WM, Sabater JR, Szelenyi S, Bahre M. Comparative effects of a fixed combination of reproterol hydrochloride and disodium cromoglycate with each agent alone on antigen-induced airway responses in sheep. Pulm Pharmacol Ther 1998: 11: 271-6.
190. Clark JM, Abraham WM, Fishman CE, Forteza R, Ahmed A, Cortes A, Warne RL, Moore WR, Tanaka RD. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med 1995; 152: 2076-83.
191. Fujimoto K, Kubo K, Okada K, Kobayashi T, Sekiguchi M, Sakai A. Effect of the 21-aminosteroid U-74006F on antigen-induced bronchoconstriction and bronchoalveolar eosinophilia in allergic sheep. Eur Respir J 1996; 9: 2044-9.
192. Abraham WM, Oliver W Jr, Welker MJ, King MM, Wanner A, Sackner MA. Differences in airway reactivity in normal and allergic sheep after exposure to sulfur dioxide. J Appl Physiol 1981; 51: 1651-6.
193. Abraham WM, Ahmed A, Sabater JR, Lauredo IT, Botvinnikova Y, Bjercke RJ, Hu X, Revelle BM, Kogan TP, Scott IL, Dixon RA, Yeh ET, Beck PJ. Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep. Am J Respir Crit Care Med 1999; 159: 1205-14.
194. Abraham WM, Gill A, Ahmed A, Sielczak MW, Lauredo IT, Botinnikova Y, Lin KC, Pepinsky B, Leone DR, Lobb RR, Adams SP. A small-molecule, tight-binding inhibitor of the integrin alpha(4)beta(1) blocks antigen-induced airway responses and inflammation in experimental asthma in sheep. Am J Respir Crit Care Med 2000; 162: 603-11.
195. Wagner EM. Effects of edema on small airway narrowing. J Appl Physiol 1997; 83: 784-91.
196. Wagner EM. TNF-alpha induced bronchial vasoconstriction. Am J Physiol Heart Circ Physiol 2000; 279: H946-51.
197. Mezey RJ, Cohn MA, Fernandez RJ, Januszkiewicz AJ, Wanner A. Mucociliary transport in allergic patients with antigen-induced bronchospasm. Am Rev Respir Dis 1978; 118: 677-84.
198. Allegra L, Abraham WM, Chapman GA, Wanner A. Duration of mucociliary dysfunction following antigen challenge. J Appl Physiol 1983; 55: 726-30.
199. O'Riordan TG, Mao Y, Otero R, Lopez J, Sabater JR, Abraham WM. Budesonide affects allergic mucociliary dysfunction. J Appl Physiol 1998; 85: 1086-91.
200. Tomioka K, Garrido R, Ahmed A, Stevenson JS, Abraham WM. YM461, a PAF antagonist, blocks antigen-induced late airway responses and airway hyperresponsiveness in allergic sheep. Eur J Pharmacol 1989; 170: 209-15.
201. Wright CD, Havill AM, Middleton SC, Kashem MA, Lee PA, Dripps DJ, et al. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma. J Pharmacol Exp Ther 1999; 289: 1007-14.
202. Abraham WM, Ahmed A, Serebriakov I, Carmillo AN, Ferrant J, de Fougerolles AR, et al. A monoclonal antibody to alpha1 beta1 blocks antigen-induced airway responses in sheep. Am J Respir Crit Care Med 2004; 169: 97-104.
203. Patterson R, Harris KE. IgE-mediated rhesus monkey asthma: natural history and individual animal variation. Int Arch Allergy Immunol 1992; 97: 154-9.
204. Hamel R, McFarlane CS, Ford-Hutchinson AW. Late pulmonary responses induced by Ascaris allergen in conscious squirrel monkeys. J Appl Physiol 1986; 61: 2081-7.
205. Schelegle ES, Gershwin LJ, Miller LA, Fanucchi MV, Van Winkle LS, Gerriets JP, et al. Allergic asthma induced in rhesus monkeys by house dust mite (Dermatophagoides farinae). Am J Pathol 2001; 158: 333-41.
206. Gundel RH, Wegner CD, Letts LG Antigen-induced acute and late-phase responses in primates. Am Rev Respir Dis 1992; 146: 369-73.
207. Turner CR, Andresen CJ, Smith WB, Watson JW. Characterization of a primate model of asthma using anti-allergy/anti-asthma agents. Inflamm Res 1996; 45: 239-45.
208. Turner CR, Breslow R, Conklyn MJ, Andresen CJ, Patterson DK, Lopez-Anaya A, et al. In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma. J Clin Invest 1996; 97: 381-7.
209. Turner CR, Smith WB, Andresen CJ, Swindell AC, Watson JW. Leukotriene D4 receptor antagonism reduces airway hyperresponsiveness in monkeys. Pulm Pharmacol 1994; 7: 49-58.
210. Yasue M, Nakamura S, Yokota T, Okudaira H, Okumura Y. Experimental monkey model sensitized with mite antigen. Int Arch Allergy Immunol 1998; 115: 303-11.
211. Bolton PB, Lefevre P, McDonald DM. Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways. Am J Respir Crit Care Med 1997; 155: 1428-35.
212. Gundel RH, Wegner CD, Torcellini CA, Clarke CC, Haynes N, Rothlein R, et al. Endothelial leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late-phase airway obstruction in monkeys. J Clin Invest 1991; 88: 1407-11.
213. Madwed JB, Jackson AC. Determination of airway and tissue resistances after antigen and methacholine in nonhuman primates. J Appl Physiol 1997; 83: 1690-6.
214. Black KR, Suki B, Madwed JB, Jackson AC. Airway resistance and tissue elastance from input or transfer impedance in bronchoconstricted monkeys. J Appl Physiol 2001; 90: 571-8.
215. Jones TR, McAuliffe M, McFarlane CS, Piechuta H, Macdonald D, Rodger IW. Effects of a selective phosphodiesterase IV inhibitor (CDP-840) in a leukotriene-dependent non-human primate model of allergic asthma. Can J Physiol Pharmacol 1998; 76: 210-7.
216. Billah MM, Cooper N, Minnicozzi M, Warneck J, Wang P, Hey JA, et al. Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)- 8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor. J Pharmacol Exp Ther 2002; 302: 127-37.
217. Hart TK, Cook RM, Zia-Amirhosseini P, Minthorn E, Sellers TS, Maleeff BE, et al. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys. J Allergy Clin Immunol 2001; 108: 250-7.
218. Hart TK, Blackburn MN, Brigham-Burke M, Dede K, Al-Mahdi N, Zia-Amirhosseini P, et al. Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clin Exp Immunol 2002; 130: 93-100.
219. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2144-8.
220. Chen CY, Bonham AC, Schelegle ES, Gershwin LJ, Plopper CG, Joad JP Extended allergen exposure in asthmatic monkeys induces neuroplasticity in nucleus tractus solitarius. J Allergy Clin Immunol 2001; 108: 557-62.
221. Zou J, Young S, Zhu F, Gheyas F, Skeans S, Wan Y, et al. Microarray profile of differentially expressed genes in a monkey model of allergic asthma. Genome Biol 2002; 3: research0020.
222. Oldham MJ, Phalen RF, Huxtable RF. Growth of the ferret tracheobronchial tree. Lab Anim Sci 1990; 40: 186-91.
223. Leigh MW, Gambling TM, Carson JL, Collier AM, Wood RE, Boat TF. Postnatal development of tracheal surface epithelium and submucosal glands in the ferret. Exp Lung Res 1986; 10: 153-69.
224. Plopper CG, Hill LH, Mariassy AT. Ultrastructure of the nonciliated bronchiolar epithelial (Clara) cell of mammalian lung. III. A study of man with comparison of 15 mammalian species. Exp Lung Res 1980; 1: 171-80.
225. Collie MH, Rushton DI, Sweet C, Smith H. Studies of influenza virus infection in newborn ferrets. J Med Microbiol 1980; 13: 561-71.
226. Jakeman KJ, Rushton DI, Smith H, Sweet C. Exacerbation of bacterial toxicity to infant ferrets by influenza virus: possible role in sudden infant death syndrome. J Infect Dis 1991; 163: 35-40
227. Geissler M, Held M, Hahn HL. A model for the shift from serous to mucous glands in airway disease: Chronic inhalation of nicotine. Atemw.-Lungenkrkh 1990; 16 (Suppl. 1): S13-4.
228. Khan S, Liu YC, Khawaja AM, Manzini S, Rogers DF. Effect of the long-acting tachykinin NK(1) receptor antagonist MEN 11467 on tracheal mucus secretion in allergic ferrets. Br J Pharmacol 2001; 132: 189-96.
229. Kuss H, Hoefgen N, Johanssen S, Kronbach T, Rundfeldt C. In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4yl)- [1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration. J Pharmacol Exp Ther 2003; 307: 373-85.
230. Moise NS, Wiedenkeller D, Yeager AE, Blue JT, Scarlett J. Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). J Am Vet Med Assoc 1989; 194: 1467-73.
231. Padrid P. Chronic lower airway disease in the dog and cat. Probl Vet Med 1992; 4: 320-44.
232. Padrid P, Snook S, Finucane T, Shiue P, Cozzi P, Solway J, Leff AR. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am J Respir Crit Care Med 1995; 151: 184-93.
233. Kirschvink N: The cat as an alternative model for allergic asthma. III. Workshop on asthma animal model, 23-24, January 2004, Hannover
234. Osborne ML, Evans TW, Sommerhoff CP, Chung KF, Hirshman CA, Boushey HA, Nadel JA. Hypotonic; and isotonic aerosols increase bronchial reactivity in Basenji greyhound dogs. Am. Rev. Respir. Dis 1987; 135: 345-9
235. Krell RD. Investigation of the role of histamine in antigen-induced bronchoconstriction in the ascaris-hypersensitive dog. Br J Pbarmacol 1978; 62: 519-28.
236. Chung KF, Becker AB, Lazarus SC, Frick OL, Nadel JA, Gold WM. Antigen-induced airway hyperresponsiveness and pulmonary inflammation in allergic dogs. J Appl Physiol 1985; 58: 1347-53.
237. Hahn HL, Schroeter V, Pech K, Szelenyi I. Role of the larynx in allergen-induced bronchoconstriction. FASEB J 1996; 48: A364.
238. Dain D, Gold WM. Mechanical properties of the lungs and experimental asthma in conscious allergic dogs. J Appl Physiol 1975; 38: 96-100.
239. Lewis AJ, Kirchner T, Dervinis A, Rosenthale ME. Ascaris-induced allergic asthma in the conscious dog: a model for the pharmacologic modulation of immediate type hypersensitivity. J. Pharmacol. Methods 1982; 7: 35-46.
240. Redman TK, Rudolph K, Barr EB, Bowen LE, Muggenburg BA, Bice DE. Pulmonary immunity to ragweed a Beagle dog model of allergic asthma. Exp Lung Res 2001; 27: 433-51.
241. Davis MS, Freed AN. Repeated hyperventilation causes peripheral airways inflammation, hyperreactivity, and impaired bronchodilation in dogs. Am J Respir Crit Care Med 2001; 164: 785-9.
242. Davis MS, McKiernan B, McCullough S, Nelson S Jr, Mandsager RE, Willard M, et al. Racing Alaskan sled dogs as a model of "ski asthma". Am J Respir Crit Care Med 2002; 166: 878-82.
243. Marx D., Herold H, Poppe H, Szelenyi I. Allergy induced in domestic pigs: a new experimental tool for detection of allergically induced dermatitis, rhinitis and asthma (abstract). Arch Pharmacol 1996; 353(Suppl.): R79.
244. Mitchell HW, Turner DJ, McFawn PK. Compliance and stability of the bronchial wall in a model of allergen-induced lung inflammation. J Appl Physiol 1999; 86: 932-7.
245. Fornhem C, Kumlin M, Lundberg JM, Alving K. Allergen-induced late-phase airways obstruction in the pig: mediator release and eosinophil recruitment. Eur Respir J 1995; 8: 1100-9
246. Sylvin H, Matvienko O, Leonchiks A, Alving K, van der Ploeg I. Molecular cloning, expression, and purification of pig interleukin-5. Immunogenetics 2000; 51: 59-64.
247. Sylvin H, Dahlback M, Van Der Ploeg I, Alving K. The tryptase inhibitor APC-366 reduces the acute airway response to allergen in pigs sensitized to Ascaris suum. Clin Exp Allergy 2002; 32: 967-71.
248. Lowell FC. Observation on heaves. An asthma-like syndrome in the horse. J Allergy 1964; 35: 322-30.
249. McPherson EA, Lawson GHK, Murphy JR, Nicholson JM, Fraser, JA, Breeze RG, Pirie HM. Chronic obstructive pulmonary disease: Identification of affected horses. Eq Vet J 1978; 10: 47-53.
250. Franchini M, Gilli U, Akens MK, Fellenberg RV, Bracher V. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD). Vet. Immunol. Immunopathol 1998; 66: 53-65.
251. Eder C, Crameri R, Mayer C, Eicher R, Straub R, Gerber H, et al. Allergen-specific IgE levels against crude mould and storage mite extracts and recombinant mould allergens in sera from horses affected with chronic bronchitis. Vet Immunol Immunopathol 2000: 73: 241-53.
252. Lavoie JP, Maghni K, Desnoyers M, Taha R, Martin JG, Hamid QA. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. Am J Respir Crit Care Med 2001; 164: 1410-3.
253. Henig NR, Aitken ML, Liu MC, Yu AS, Henderson WR Jr. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses.Am J Respir Crit Care Med 2000; 162: 523-7.
254. Borish LC, Nelson HS, Corren J, Bensch G, Busse WW, Whitmore JB, et al. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol 2001; 107: 963-70.
255. Bryan SA, O'Connor BJ, Matti S, Leckie MJ, Kanabar V, Khan J, et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2149-53.
256. Lundgren R, Soderberg M, Horstedt P, Stenling R. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1988; 1: 883-9.
257. The Childhood Asthma Management Program Research Group Long-Term Effects of Budesonide or Nedocromil in Children with Asthma N Engl J Med 2000; 343: 1054-1063.
258. Corris PA, Dark JH. Aetiology of asthma: lessons from lung transplantation. Lancet 1993; 341: 1369-71
259. Holgate ST. Asthma: more than an inflammatory disease. Curr Opin Allergy Clin Immunol 2002; 2: 27-9.
260. Leuenberger P, Kunzli N, Ackermann-Liebrich U, Schindler C, Bolognini G, et al. [Swiss Study on Air Pollution and Lung Diseases in Adults (SAPALDIA)] Schweiz Med Wochenschr 1998; 128: 150-61
261. Spina D, Page CP Asthma - a need for a rethink? Trends Pharmacol Sci 2002; 23: 311-5.
262. Heuer HO, Wenz B, Jennewein HM, Urich K Heuer HO, Wenz B, et al. Dissociation of airway responsiveness and bronchoalveolar lavage (BAL) cell composition in sensitized guinea-pigs after daily inhalation of ovalbumin. Clin Exp Allergy 1994; 24: 682-9.
263. Drazen JM, Finn PW, De Sanctis GT. Mouse models of airway responsiveness: physiological basis of observed outcomes and analysis of selected examples using these outcome indicators. Annu Rev Physiol 1999; 61: 593-625.
264. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmograpby. Am J Respir Crit Care Med 1997; 156: 766-75.
265. Expert panel report 2: guidelines for the management and treatment of asthma 1998 URL: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm
266. Chung KF, Aizawa H, Leikauf GD, Ueki IF, Evans TW, Nadel JA. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J Pharmacol Exp Ther 1986; 236: 580-4.
267. Nagase T, Ishii S, Katayama H, Fukuchi Y, Ouchi Y, Shimizu T. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes. Am J Respir Crit Care Med 1997; 156: 1621-7.
268. Finnerty JP, Twentyman OP, Harris A, Palmer JB, Holgate ST. Effect of GR32191, a potent thromboxane receptor antagonist, on exercise induced bronchoconstriction in asthma. Thorax 1991; 46: 190-2.
269. Frode TS, Medeiros YS. The puzzle of asthma treatment: animal models to genetic studies. Curr Pharm Des 2005; 11(19): 2515-24.
270. Psarras S, Caramori G, Contoli M, Papadopoulos N, Papi A. Oxidants in asthma and in chronic obstructive pulmonary disease (COPD). Curr Pharm Des 2005; 11(16): 2053-62.
271. Sakoff JA, McCluskey A. Protein phosphatase inhibition: structure based design. Towards new therapeutic agents. Curr Pharm Des 2004; 10(10): 1139-59.